¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2020 ´ëÇÑ°£ÇÐȸ Áö¹æ°£¿¬±¸È¸ NAFLD ½ÉÆ÷Áö¾ö : 2020-10-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2020 ´ëÇÑ°£ÇÐȸ Áö¹æ°£¿¬±¸È¸ NAFLD ½ÉÆ÷Áö¾ö : 2020-10-24
±³À°ÀÏÀÚ : 2020-10-24
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2020 ´ëÇÑ°£ÇÐȸ Áö¹æ°£¿¬±¸È¸ NAFLD ½ÉÆ÷Áö¾ö      
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁö¹æ°£¿¬±¸È¸  
´ã´çÀÚ : Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005  
À̸ÞÀÏ : kaslsymposium@hbni.co.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í È¸¿ø,ÀüÀÓÀÇ,Àü°øÀÇ 3¸¸¿ø, ºñȸ¿ø 4¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 10¿ù 24ÀÏ ¿Â¶óÀΠ08:50~08:55 Opening Remark  ÀÌÁø¿ì(Áö¹æ°£¿¬±¸È¸ ȸÀå) 
±âŸ 10¿ù 24ÀÏ ¿Â¶óÀΠ08:55~09:00 Congratulatory Remark  ÀÌÇÑÁÖ(´ëÇÑ°£ÇÐȸ ÀÌ»çÀå) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ09:00~09:25 Metabolic Dysfunction Associated Fatty Liver: Better Definition?  Vincent Wong(The Chinese Univ. of Hong Kong Hong Kong) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ09:25~09:50 Natural Course: How Can We Change?  ±è»ó±Õ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ09:50~10:15 Lean NAFLD: Better or Worse than Obese NAFLD?  ±èÈÖ¿µ(ÀÌÈ­ÀÇ´ë) 
È޽Ġ10¿ù 24ÀÏ ¿Â¶óÀΠ10:15~10:25 Break  () 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ10:25~10:50 Screening: Who and When by Which Tools?  ÀÌÇý¿ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ10:50~11:15 Biochemical/Equation Biomarkers  ±è½Â¾÷(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ11:15~11:40 Imaging Biomarkers  ÃÖÁØÀÏ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ11:40~12:05 Omics  ±è¿ø(¼­¿ïÀÇ´ë) 
½Ä»ç 10¿ù 24ÀÏ ¿Â¶óÀΠ12:05~12:40 Lunch  () 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ12:40~13:05 Effective Referrals: The Role of Pimary Care Physicians  ¼Ûµµ¼±(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ13:05~13:30 Exercise with Diet and Alcohol  Àü´ë¿ø(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ13:30~13:55 Pharmacological Treatment: Now and Future  Yoshio Sumida(Aichi Medical Univ. Japan) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ13:55~14:20 Monitoring and Outcome Assessment: How and When by Which Tools?  ±è¹®¿µ(¿¬¼¼¿øÁÖÀÇ´ë) 
È޽Ġ10¿ù 24ÀÏ ¿Â¶óÀΠ14:20~14:30 Break  () 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ14:30~14:55 Insulin Resistance: Repositioning of Anti-Diabetics  ÀÌÁ¤ÀÏ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ14:55~15:20 Cardiovascular Risk: Repositioning of Anti-Lipids  À庴±¹(°è¸íÀÇ´ë) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ15:20~15:45 Oncologic Risk: Assessment and Surveillance  ¼­¿¬¼®(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10¿ù 24ÀÏ ¿Â¶óÀΠ15:45~16:10 Beyond Medical Intervention  ÀÌ¿µ¼±(°í·ÁÀÇ´ë) 
±âŸ 10¿ù 24ÀÏ ¿Â¶óÀΠ16:10~16:15 Closing Remark  ±è½Â¾÷(Áö¹æ°£¿¬±¸È¸ ÇмúÀÌ»ç) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2020 ´ëÇÑ°£ÇÐȸ Áö¹æ°£¿¬±¸È¸ NAFLD ½ÉÆ÷Áö¾ö : 2020-10-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ ¿Â¶óÀÎ ¿¬¼ö±³À° : 2020-10-24
´ÙÀ½±Û ´ëÇÑÇǺΰúÇÐȸ Á¦5Â÷ ´ëÇѼչßÅéÇÐȸ Çмú´ëȸ : 2020-10-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 35 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 34 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 30 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 26 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 30 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 43 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 24 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 22 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 21 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 19 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 22 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 25 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 27 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷